Skip to main content

Cigna Value Stock - Dividend - Research Selection


ISIN: US1255231003 , WKN: A2PA9L

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Why the Market Dipped But Cigna (CI) Gained Today

Cigna (CI) closed at $348.78 in the latest trading session, marking a +0.78% move from the prior day.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

The Cigna Group Foundation Announces New Grant Program To Address Youth Mental Health Crisis

As part of its ongoing commitment to community health and vitality, global health company The Cigna Group (NYSE: CI) today announced a multiyear philanthropic and community engagement initiative focused on partnering with nonprofit organizations with expertise in three essential areas: improving youth mental health, bolstering veteran mental health through housing stability and services, and addressing barriers to health equity. As part of this engagement initiative, The Cigna Group Foundation w

The Cigna Group's (NYSE:CI) CEO Compensation Looks Acceptable To Us And Here's Why

Key Insights Cigna Group will host its Annual General Meeting on 24th of April Salary of US$1.50m is part of CEO David...

Hospital survey weakened 'dramatically' in March, says TD Cowen

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Cigna Group stock underperforms Wednesday when compared to competitors

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

3 Weight-Loss ETFs to Profit From the Obesity Drug Boom

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

U.S. Probes High Generic Drug Prices

The U.S. government is investigating whether the consolidation of health insurers, pharmacy benefit managers and pharmacies is fueling high drug costs. The Department of Health and Human Services’ Office of Inspector General said it is examining whether health insurers' shared ownership of pharmacy-benefit managers and pharmacies has played a role in high drug prices. “We will determine the impact of related entity transactions within select vertically integrated entities on the prices for covered Part D drugs,” the OIG said in an undated post on its website.

EXPLAINER-Why are US pharmacy benefit managers under fire?

Pharmacy benefit managers (PBMs) are in the crosshairs of Republicans and Democrats in Congress but have so far dodged any new litigation or reforms that had been targeted for inclusion in last month's U.S. government budget deal. Many lawmakers, drugmakers and government officials have pointed a finger at these industry middle men, suggesting they play a critical role in high prescription drug costs in the United States. The following is what you need to know about PBMs.